Clarity Pharmaceuticals Ltd
CU6•Health Care•Biotechnology•Last updated: Dec 25
About
Clarity Pharmaceuticals Ltd is a clinical-stage radiopharmaceutical company focused on developing next-generation products for the treatment of serious diseases. The company specializes in the development of targeted theranostic (therapy and diagnostic) radiopharmaceuticals for the treatment of cancer. Clarity's pipeline includes products for prostate cancer, neuroblastoma, and other serious conditions, utilizing its proprietary SAR Technology platform.
Share Price Chart
Company Details
- Sector
- Health Care
- Industry
- Biotechnology
- ASX Code
- CU6
Related Shares
Investor Resources
Should you buy Clarity Pharmaceuticals Ltd right now?
While CU6 looks interesting right now, our experts have just put together a full report on the ultimate ASX investment portfolio - designed for growth and passive income.
Join the Rask weekly investment newsletter to get the names, right now